Company intelligence / Profile preview

Soliton

Houston, Texas, United Statessolitontech.com ↗

Ownership: Private
Employees: ~8
Development stage: Other

Overview

Soliton's RAP device demonstrated in clinical trials the ability to remove tattoos in up to one-third the time of current laser methods. The company completed a pivotal clinical trial for cellulite reduction with positive results prior to acquisition. The RAP platform was FDA-cleared as an accessory to lasers for tattoo removal and showed promise in additional aesthetic indications such as cellulite and potential scar treatments

Therapeutic areas: DermatologyMetabolic Disorders
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

MD Anderson Cancer Center / University of Texas — exclusive licensee of core technologyEmphysys Technology Solutions — design partnership on engineering aspectsSanmina Corporation — manufacturing partner for medical devicesGE’s Unison — design/manufacturing support partner

Beyond the preview

Go deeper on Soliton.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soliton.

Explore the full profile